Rational bases for using oxygen-ozonetherapy as a biological response modifier in sickle cell anemia and beta-thalassemia: a therapeutic perspective. [electronic resource]
- Journal of biological regulators and homeostatic agents
- 38-44 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't